12 years is a long wait to play the sequel to one of your favourite games of all time. During that decade-plus stretch, I’ve re-played the original Alien: Isolation multiple times, analysed its ...

Sega and Creative Assembly have finally officially revealed Alien: Isolation 2 with a new trailer at Summer Game Fest 2026. While the trailer stops short of announcing a release date or even a release ...

A Florida deputy dismissed the citation months later due to "lack of evidence" Getty Florida influencer Katie went viral after receiving a distracted driving citation for using her right hand to hold ...

In case you've faced some hurdles solving the clue, Hand-y salon treatments, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and ...

Deaf children can now hear thanks to a new treatment that repairs a defective gene. Researchers associated with the biotech company Regeneron Pharmaceuticals unveiled the successful gene therapy last ...

Chemotherapy-induced hand-foot syndrome (HFS) is a dose-limiting dermatological toxicity characterised by erythema, swelling, dysaesthesia and pain of the palms and soles. It arises most commonly with ...

If you’ve started exploring therapy for OCD, you’ve likely come across different approaches. There's exposure and response prevention (ERP), acceptance and commitment therapy (ACT), and ...

Short bowel syndrome (SBS) occurs when a large portion of the small intestine is missing, damaged, or affected by disease, making it difficult to absorb nutrients and fluids. Treatment varies by stage ...

Overall, 91% of patients agreed that they would like to know about treatment options besides chemotherapy. Patients with endometrial cancer want an individualized, collaborative approach to their ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

CHICAGO--(BUSINESS WIRE)--Emalex Biosciences today announced that the first patient was dosed in its Expanded Access Program for ecopipam, an investigational first-in-class D1 receptor antagonist in ...